Diaceutics PLC
DXRX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £106 | £73 | £64 | £86 |
| - Cash | £13 | £17 | £20 | £20 |
| + Debt | £1 | £1 | £1 | £2 |
| Enterprise Value | £94 | £58 | £45 | £68 |
| Revenue | £32 | £24 | £20 | £14 |
| % Growth | 35.7% | 21.5% | 39.9% | – |
| Gross Profit | £28 | £20 | £14 | £11 |
| % Margin | 87.9% | 83.2% | 72% | 75.8% |
| EBITDA | £3 | £2 | £4 | £2 |
| % Margin | 8.6% | 10% | 18.5% | 16.8% |
| Net Income | -£2 | -£2 | £1 | £1 |
| % Margin | -5.3% | -7.4% | 3.7% | 4% |
| EPS Diluted | -0.02 | -0.021 | 0.008 | 0.007 |
| % Growth | 2.4% | -346.4% | 27.3% | – |
| Operating Cash Flow | £1 | £1 | £5 | £1 |
| Capital Expenditures | -£5 | -£5 | -£5 | -£6 |
| Free Cash Flow | -£4 | -£4 | £0 | -£5 |